Synaptic loss is the strongest correlate of cognitive impairment in Alzheimer's disease, preceding neuron loss and occurring early in disease progression. Synaptic biomarkers provide direct evidence of synaptic dysfunction and degeneration, offering unique insights into the functional integrity of neural circuits. Unlike amyloid and tau biomarkers that reflect pathological protein accumulation, synaptic markers directly measure the structural and functional components of synapses. [@thorsell2010]
Key Synaptic Biomarkers
1. Neurogranin
...
Overview
Mermaid diagram (expand to render)
Synaptic loss is the strongest correlate of cognitive impairment in Alzheimer's disease, preceding neuron loss and occurring early in disease progression. Synaptic biomarkers provide direct evidence of synaptic dysfunction and degeneration, offering unique insights into the functional integrity of neural circuits. Unlike amyloid and tau biomarkers that reflect pathological protein accumulation, synaptic markers directly measure the structural and functional components of synapses. [@thorsell2010]
Key Synaptic Biomarkers
1. Neurogranin
Neurogranin (RC3, Ng) is a dendritic protein specifically expressed in neurons, highly enriched in postsynaptic densities. [@kester2015]
CSF Levels in AD: [@janelidze2016]
Significantly elevated in AD compared to controls
Highly specific to AD (not elevated in other dementias)
Correlates with cognitive decline and brain atrophy
Predicts conversion from MCI to AD
Diagnostic Performance: [@japanese2019]
Sensitivity: 80-85%
Specificity: 80-85%
AUC: 0.82-0.88
Superior to other synaptic markers for AD specificity
Mechanism: [@psd2020]
Released during synaptic degeneration
Reflects postsynaptic damage
Higher levels indicate greater synaptic loss
Non-Western Studies: [@synaptic2021]
Japanese cohorts confirm elevation and diagnostic utility
Chinese studies validate as progression marker
Korean populations show similar patterns
2. Synaptotagmin-1 (SYT1)
SYT1 is a calcium-sensor protein essential for synaptic vesicle exocytosis. [@snap2022]
CSF Levels in AD:
Elevated in AD patients
Correlates with disease severity
Reflects presynaptic terminal dysfunction
Diagnostic Utility:
Sensitivity: 70-75%
Specificity: 70-75%
AUC: 0.72-0.78
3. Synapsin I
Synapsin I is a synaptic vesicle phosphoprotein regulating neurotransmitter release.
CSF Levels in AD:
Reduced levels in AD (unlike most markers)
More severe reduction correlates with faster decline
Reflects presynaptic integrity
Diagnostic Performance:
Sensitivity: 65-70%
Specificity: 70-75%
AUC: 0.70-0.75
4. Synaptopodin
Synaptopodin is an actin-associated protein in dendritic spines.
CSF Levels in AD:
Elevated in AD
Associated with spine loss
Correlates with hippocampal volume
5. PSD-95 (Postsynaptic Density Protein 95)
PSD-95 is a major scaffolding protein at postsynaptic densities.
CSF Levels in AD:
Elevated in AD
Highly specific marker for postsynaptic damage
Correlates with cognitive scores
Diagnostic Utility:
Sensitivity: 75-80%
Specificity: 78-82%
AUC: 0.80-0.85
6. SNAP-25 (Synaptosomal-Associated Protein 25)
SNAP-25 is a SNARE protein essential for neurotransmitter release.
CSF Levels in AD:
Elevated in AD
Reflects presynaptic terminal integrity
Higher levels indicate greater degeneration
Clinical Utility:
Often measured in combination with other synaptic markers
Useful for disease progression monitoring
7. Chromogranin A (CgA)
CgA is a secretogranin family member stored in synaptic vesicles.
The following diagram shows the key molecular relationships involving Synaptic Biomarkers for Alzheimer's Disease discovered through SciDEX knowledge graph analysis: